A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single Oral Doses

Clinical trial NCT01998646 · COMPLETED

Trial details

NCT number: NCT01998646
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASP4058 Healthy Subjects Food Effect of ASP4058

Start date: 2010-08-01
Primary completion: 2012-07-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.